You are here: Industry Insights > Dexamethasone

News List

Progress of Research on Key COVID-19 Treatments Deborah Seah
December 17, 2021
At the point of writing the COVID-19 pandemic is nearing its two-year run with more than four million deaths and a total of 219 million cases worldwide. Scientists across the world are still scrambling to better understand...
Dexamethasone API Bulk Price and Manufacturers in China PharmaSources
June 04, 2021
Dexamethasone is a synthetic corticosteroid that suppresses the action of your immune system towards various diseases. It thus aids in reducing symptoms such as redness, swelling, and allergic reactions.
FDA Approves Darzalex Faspro, Kyprolis, and Dexamethasone for Multiple Myeloma AmericanPharmaceuticalReview
December 03, 2021
The FDA has approved daratumumab + hyaluronidase-fihj (Darzalex Faspro, Janssen Biotech, Inc.) and carfilzomib (Kyprolis, Amgen, Inc.) plus dexamethasone for adult patients with relapsed or refractory multiple myeloma who have received 1 to 3 prior ...
Dexamethasone Studied for Treatment of Heavy Menstrual Bleeding drugs
August 19, 2021
Low-dose dexamethasone may reduce heavy menstrual bleeding (HMB) when taken during the luteal phase of menstrual cycles, according to a study published online recently in EBioMedicine.
Dexamethasone Can Help the Sickest COVID Patients Survive. So Why Are Too Few Getting It? drugs
August 18, 2021
There's strong evidence that the steroid drug dexamethasone can significantly lower hospitalized patients' risk of dying from COVID-19, but many who might benefit from it the most aren't getting it.
Dexamethasone Underused for Adults Hospitalized With COVID-19 drugs
August 17, 2021
For adults hospitalized with COVID-19, dexamethasone and remdesivir use increased over time, although dexamethasone is still somewhat underused, according to a study published online Aug. 17 in the Annals of Internal Medicine.
NPPA fixes ceiling prices of 355 medicines and 882 formulations expresspharma
July 30, 2021
The authority fixes the ceiling prices of scheduled formulations as per the provisions of DPCO, 2013, and monitors the prices of non-scheduled drugs so as to ensure that their prices do not increase beyond 10 per cent in a year.
FDA Approves Belumosudil for Graft-Versus-Host Disease americanpharmaceuticalreview
July 20, 2021
The FDA approved daratumumab and hyaluronidase-fihj (Darzalex Faspro, Janssen Biotech, Inc.) in combination with pomalidomide and dexamethasone for adult patients with multiple myeloma who have received at least one prior line of therapy including ...
Targeted drug delivery enabled by genetically engineered nanoparticles europeanpharmaceuticalreview
June 18, 2021
In a pre-clinical study, researchers were able to genetically engineer cell membrane-coated nanoparticles to deliver dexamethasone directly to the inflamed lungs of mice.
EC approves new Sarclisa indication pharmatimes
April 20, 2021
The European Commission has approved Sanofi’s Sarclisa in combination with standard of care regimen carfilzomib and dexamethasone (Kd) for the treatment of relapsed multiple myeloma.

Previous page 1 2 3 4 Next page